On June 9, 2016, the U.S. International Trade Commission (“Commission”) issued a press release announcing their vote to institute an investigation of Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of Production (Inv. No. 337-TA-1005).

By way of background, this investigation is based on a May 10, 2016 complaint filed by Ajinomoto Co., Inc. of Japan and Ajinomoto Heartland Inc. of Chicago, Illinois alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain L-tryptophan and L-tryptophan products that infringe one or more claims of U.S. Patent Nos. 7,666,655 and 6,180,373. See our May 10, 2016 post for more details on the complaint.

According to the Notice of Investigation, the Commission has identified CJ CheilJedang Corp. of South Korea, CJ America, Inc. of Downers Grove, Illinois, and PT CheiJedang Indonesia of Indonesia as the respondents. The Notice of Investigation further indicates that the Office of Unfair Imports Investigation will not participate as a party in this investigation.

Lastly, Chief ALJ Bullock issued a notice indicating that Theodore R. Essex will be the presiding Administrative Law Judge in this matter.